Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza A virus infection

Journal of Biological Chemistry

Volumn 287, Issue 42, 2012, Pages 35324-35332

  Denisova, Oxana V ^a   Kakkola, Laura ^a   Feng, Lin ^b   Stenman, Jakob ^a,b   Nagaraj, Ashwini ^a   Lampe, Johanna ^a   Yadav, Bhagwan ^a   Aittokallio, Tero ^a   Kaukinen, Pasi ^c   Ahola, Tero ^c   Kuivanen, Suvi ^d   Vapalahti, Olli ^d,e   Kantele, Anu ^e   Tynell, Janne ^f   Julkunen, Ilkka ^f   Kallio Kokko, Hannimari ^g   Paavilainen, Henrik ^h   Hukkanen, Veijo ^h   Elliott, Richard M ⁱ   De Brabander, Jef K ^j   Saelens, Xavier ^k   Kainov, Denis E ^a   more..

^a UNIVERSITY OF HELSINKI   (Finland)

^b MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^g Institute of Clinical Medicine   (Finland)

^h UNIVERSITY OF TURKU   (Finland)

ⁱ UNIVERSITY OF ST ANDREWS   (United Kingdom)

^j UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^k GHENT UNIVERSITY   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL ACTIVITIES; ANTIVIRAL AGENTS; ANTIVIRALS; BROAD SPECTRUM; CELL TYPES; GEMCITABINE; INFLUENZA A VIRUS; PHASE II; VIRAL RNA;

RNA;

VIRUSES;

ADENOSINE TRIPHOSPHATASE INHIBITOR; BORTEZOMIB; CXCL1 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GEMCITABINE; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; OBATOCLAX; PROTEIN MCL 1; RANTES; SALIPHENYLHALAMIDE; TANESPIMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; BUNYAVIRUS; CANCER CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG SCREENING; HERPES VIRUS; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARAMYXOVIRUS; PICORNAVIRUS; PIGMENT EPITHELIUM; POXVIRUS; PRIORITY JOURNAL; TOGAVIRUS; VIRUS ENTRY; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSCRIPTION;

AMIDES; ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; DEOXYCYTIDINE; DOGS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRROLES; RNA, VIRAL; SALICYLATES; VERO CELLS; VIRUS REPLICATION;

EID: 84867430896     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.392142     Document Type: Article

References (29)

1. Gu, J., Xie, Z., Gao, Z., Liu, J., Korteweg, C., Ye, J., Lau, L. T., Lu, J., Gao, Z., Zhang, B., McNutt, M. A., Lu, M., Anderson, V. M., Gong, E., Yu, A. C., and Lipkin, W. I. (2007) H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 370, 1137-1145 (Pubitemid 47464584)
2. Kurtz, J., Manvell, R. J., and Banks, J. (1996) Avian influenza virus isolated from a woman with conjunctivitis. Lancet 348, 901-902 (Pubitemid 26320930)
3. Weinheimer, V. K., Becher, A., Tönnies, M., Holland, G., Knepper, J., Bauer, T. T., Schneider, P., Neudecker, J., Ruckert, J. C., Szymanski, K., Temmesfeld- Wollbrueck, B., Gruber, A. D., Bannert, N., Suttorp, N., Hippenstiel, S., Wolff, T., and Hocke, A. C. (2012) J. Infect. Dis., in press
4. Müller, K. H., Kakkola, L., Nagaraj, A. S., Cheltsov, A. V., Anastasina, M., and Kainov, D. E. (2012) Emerging cellular targets for influenza antiviral agents. Trends Pharm. Sci. 33, 89-99
5. Lebreton, S., Jaunbergs, J., Roth, M. G., Ferguson, D. A., and De Brabander, J. K. (2008) Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. Bioorg. Med. Chem. Lett. 18, 5879-5883
6. Lietzén, N., Ohman, T., Rintahaka, J., Julkunen, I., Aittokallio, T., Matikainen, S., and Nyman, T. A. (2011) Quantitative subcellular proteome and secretome profiling of influenza A virus-infected human primary macrophages. PLoS Pathogens 7, e1001340
7. Guse, K., Sloniecka, M., Diaconu, I., Ottolino-Perry, K., Tang, N., Ng, C., Le Boeuf, F., Bell, J. C., McCart, J. A., Ristimäki, A., Pesonen, S., Cerullo, V., and Hemminki, A. (2010) Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models. J. Virol. 84, 856-866
8. Heikkilä, O., Susi, P., Stanway, G., and Hyypiä, T. (2009) Integrin αVβ6 is a high-affinity receptor for coxsackievirus A9. J. Gen. Virol. 90, 197-204
9. Müller, K. H., Kainov, D. E., El Bakkouri, K., Saelens, X., De Brabander, J. K., Kittel, C., Samm, E., and Muller, C. P. (2011) The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections. Br. J. Pharmacol. 164, 344-357
10. Sane, J., Kurkela, S., Desdouits, M., Kalimo, H., Mazalrey, S., Lokki, M. L., Vaheri, A., Helve, T., Törnwall, J., Huerre, M., Butler-Browne, G., Ceccaldi, P. E., Gessain, A., and Vapalahti, O. (2012) Prolonged myalgia in sindbis virus infection: case description and in vitro infection of myotubes and myoblasts. J. Infect. Dis. 206, 407-414
11. Schneider, J., Dauber, B., Melén, K., Julkunen, I., and Wolff, T. (2009) Analysis of influenza B virus NS1 protein trafficking reveals a novel interaction with nuclear speckle domains. J. Virol. 83, 701-711
12. Schwarz, A. J. (1962) Preliminary tests of a highly attenuated measles vaccine. Am. J. Dis. Child 103, 386-389
13. Shi, X., and Elliott, R. M. (2009) Generation and analysis of recombinant Bunyamwera orthobunyaviruses expressing V5 epitope-tagged L proteins. J. Gen. Virol. 90, 297-306
14. Spuul, P., Balistreri, G., Hellström, K., Golubtsov, A. V., Jokitalo, E., and Ahola, T. (2011) Assembly of α virus replication complexes from RNA and protein components in a novel trans-replication system in mammalian cells. J. Virol. 85, 4739-4751
15. Jiang, X. R., Jimenez, G., Chang, E., Frolkis, M., Kusler, B., Sage, M., Beeche, M., Bodnar, A. G., Wahl, G. M., Tlsty, T. D., and Chiu, C. P. (1999) Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat. Genet. 21, 111-114
16. Michaelis, M., Geiler, J., Klassert, D., Doerr, H. W., and Cinatl, J., Jr. (2009) Infection of human retinal pigment epithelial cells with influenza A viruses. Invest. Ophthalmol. Vis. Sci. 50, 5419-5425
17. Nguyen, M., Marcellus, R. C., Roulston, A., Watson, M., Serfass, L., Murthy Madiraju, S. R., Goulet, D., Viallet, J., Bélec, L., Billot, X., Acoca, S., Purisima, E., Wiegmans, A., Cluse, L., Johnstone, R. W., Beauparlant, P., and Shore, G. C. (2007) Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis. Proc. Natl. Acad. Sci. U.S.A. 104, 19512-19517
18. Feng, L., Lintula, S., Ho, T. H., Anastasina, M., Paju, A., Haglund, C., Stenman, U. H., Hotakainen, K., Orpana, A., Kainov, D., and Stenman, J. (2012) Technique for strand-specific gene-expression analysis and monitoring of primer-independent cDNA synthesis in reverse transcription. BioTechniques 52, 263-270
19. Chase, G., Deng, T., Fodor, E., Leung, B. W., Mayer, D., Schwemmle, M., and Brownlee, G. (2008) Hsp90 inhibitors reduce influenza virus replication in cell culture. Virology 377, 431-439 (Pubitemid 351822379)
20. Dudek, S. E., Luig, C., Pauli, E. K., Schubert, U., and Ludwig, S. (2010) The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state. J. Virol. 84, 9439-9451
21. Bajwa, N., Liao, C., and Nikolovska-Coleska, Z. (2012) Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review. Expert Opin. Ther. Pat. 22, 37-55
22. Gesto, D. S., Cerqueira, N. M., Fernandes, P. A., and Ramos, M. J. (2012) Gemcitabine: a critical nucleoside for cancer therapy. Curr. Med. Chem. 19, 1076-1087
23. Meneghesso, S., Vanderlinden, E., Stevaert, A., McGuigan, C., Balzarini, J., and Naesens, L. (2012) Synthesis and biological evaluation of pyrimidine nucleoside monophosphate prodrugs targeted against influenza virus. Antiviral Res. 94, 35-43
24. Rosebeck, S., Sudini, K., Chen, T., and Leaman, D. W. (2011) Involvement of Noxa in mediating cellular ER stress responses to lytic virus infection. Virology 417, 293-303
25. Venticinque, L., and Meruelo, D. (2010) Sindbis viral vector induced apoptosis requires translational inhibition and signaling through Mcl-1 and Bak. Mol. Cancer 9, 37
26. Chen, K. F., Su, J. C., Liu, C. Y., Huang, J. W., Chen, K. C., Chen, W. L., Tai, W. T., and Shiau, C. W. (2012) A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation. Cancer Lett. 321, 27-35
27. Koskela, H. L., Eldfors, S., Ellonen, P., van Adrichem, A. J., Kuusanmäki, H., Andersson, E. I., Lagström, S., Clemente, M. J., Olson, T., Jalkanen, S. E., Majumder, M. M., Almusa, H., Edgren, H., Lepistö, M., Mattila, P., Guinta, K., Koistinen, P., Kuittinen, T., Penttinen, K., Parsons, A., Knowles, J., Saarela, J., Wennerberg, K., Kallioniemi, O., Porkka, K., Loughran, T. P., Jr., Heckman, C. A., Maciejewski, J. P., and Mustjoki, S. (2012) Somatic STAT3 mutations in large granular lymphocytic leukemia. New Engl. J. Med. 366, 1905-1913
28. Wang, W. B., Levy, D. E., and Lee, C. K. (2011) STAT3 negatively regulates type I IFN-mediated antiviral response. J. Immunol. 187, 2578-2585
29. Qin, A., Cheng, T. S., Lin, Z., Cao, L., Chim, S. M., Pavlos, N. J., Xu, J., Zheng, M. H., and Dai, K. R. (2012) Prevention of wear particle-induced osteolysis by a novel V-ATPase inhibitor saliphenylhalamide through inhibition of osteoclast bone resorption. PloS One 7, e34132